View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.
Authors: Östör, Andrew1,2,3,4 (AUTHOR) andrewostor@gmail.com, Van den Bosch, Filip5,6 (AUTHOR), Papp, Kim7,8 (AUTHOR), Keiserman, Mauro9 (AUTHOR), Blanco, Ricardo10 (AUTHOR), Crowley, Angela11 (AUTHOR), White, Douglas12,13 (AUTHOR), Biljan, Ana14 (AUTHOR), Madihlaba, Tshepiso14 (AUTHOR), Carter, Kyle14 (AUTHOR), Liu, Fang14 (AUTHOR), Soliman, Ahmed M.14 (AUTHOR), Ashley, Doug14 (AUTHOR), Chen, Michael14 (AUTHOR), Glotfelty, Lila14 (AUTHOR), Kivitz, Alan15 (AUTHOR)
Source: Rheumatology & Therapy. Dec2025, Vol. 12 Issue 6, p1103-1123. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-025-00793-3